Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Aequs Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Continuous CapEx planned, especially in aerospace, to meet increasing demand and maintain capacity utilization around 75%. Key concall takeaways from Aequs…
7 Aug 2026
Capillary Technologies India Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Revenue grew 16% year-on-year in Q3 FY26, with 22% growth for the nine months period. Key concall takeaways from Capillary Technologies India Ltd's Q3 FY26…
7 Aug 2026
JTEKT India Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
JTEKT supplies about 50%-55% of Maruti Suzuki's requirements, so growth is closely tied to Maruti, Toyota, and other OEMs. Key concall takeaways from JTEKT…
7 Aug 2026
Shivalik Bimetal Controls Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
FY25 EBITDA grew 25% YoY with margin expansion over 400 bps to 23.17%; PBT rose 30% with margins over 20%. Key concall takeaways from Shivalik Bimetal Controls…
7 Aug 2026
Relaxo Footwears Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Addition of around 100 new distributors and expansion of retail outlets by 5-10% planned. Key concall takeaways from Relaxo Footwears Ltd's Q4 FY25 earnings…
7 Aug 2026
Corona Remedies Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company plans to expand its sales force by **5-7% annually**, supporting growth and new therapy launches. Key concall takeaways from Corona Remedies Ltd's…
7 Aug 2026
Sudeep Pharma Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Currently 35%-40% utilization; no major capex planned. Key concall takeaways from Sudeep Pharma Ltd's Q3 FY26 earnings call — and how it ranks against sector…
7 Aug 2026
Fujiyama Power Systems Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
300 crores (completed faster than industrial standards). Key concall takeaways from Fujiyama Power Systems Ltd's Q3 FY26 earnings call — and how it ranks…
7 Aug 2026
Tenneco Clean Air India Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Their order book provides 100% revenue coverage through FY28, giving clear medium-term visibility. Key concall takeaways from Tenneco Clean Air India Ltd's Q3…
7 Aug 2026
Physicswallah Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Online Average Revenue Per User (ARPU) increased by ~8%, with room for further ARPU improvement due to pricing strategy and deeper market penetration. Key…
7 Aug 2026
Emmvee Photovoltaic Power Q3 FY26: Revenue ₹1,152.3 Cr | Arthneeti
Q3 FY26
Revenue for Q3 FY26 was ₹1,152.3 crores, up 118% YoY and 2% QoQ; 9 months revenue at ₹3,311.1 crores . Key concall takeaways from Emmvee Photovoltaic Power…
7 Aug 2026
Emmvee Photovoltaic Power Q2 FY26: Revenue ₹2191 Cr, EBITDA margin 35% | Arthneeti
Q2 FY26
Revenue potential seen from current 7.8 GW capacity is around ₹2191 crore in H1 FY26, indicating strong scale-up prospects. Key concall takeaways from Emmvee…
7 Aug 2026
Pine Labs Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Issuance business grew 42%, digital payments business grew 16%, contributing to overall 24% revenue growth year-over-year. Key concall takeaways from Pine Labs…
7 Aug 2026
Tata Motors Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company has strong net cash balances (₹3,900 crores as of December '25 and ₹6,100 crores on a consolidated basis). Key concall takeaways from Tata Motors…
7 Aug 2026
Schneider Electric Infrastructure Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Sales growth in H1 was 6.6%, with acceleration to 8.4% in Q2, indicating improving momentum. Key concall takeaways from Schneider Electric Infrastructure Ltd's…
7 Aug 2026
Schneider Electric Infrastructure Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Order inflows grew by 13.8% over the prior period, with a healthy pipeline and a 7.3% increase in order backlog to INR 1,086 crores. Key concall takeaways from…
7 Aug 2026
Shaily Engineering Plastics Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Current capacity of 70 to 75 million pens (80-85% utilization) is based on customer commitments, with about 50-60% backed by firm take-or-pay contracts. Key…
7 Aug 2026
Gujarat Narmada Valley Fertilizers & Chemicals Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Capex pipeline worth INR 2,800 crores includes expansions in AN melt, weak nitric acid, power and steam plant conversion, and ammonia loop expansion. Key…
7 Aug 2026
Rishi Laser Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
The new Bangalore facility (INR 15 crore CapEx) will contribute higher revenue and profitability over 3-4 years with a high turnover-to-asset ratio. Key…
7 Aug 2026
SEAMEC Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
. Key concall takeaways from SEAMEC Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
7 Aug 2026